Plasma Lipidomic Features of Adolescent Major Depressive Disorder and Lipid Changes After Fluoxetine Treatment.
Chenxi Liu, Yao Li, Hanchen Hou et al.CNS neuroscience & therapeutics
BACKGROUND: Major depressive disorder (MDD) in adolescents is a major public health concern, yet objective biological markers and treatment-related metabolic changes remain insufficiently understood. This study aimed to characterize plasma lipidomic alterations in adolescent MDD and explore lipid changes associated with fluoxetine treatment.…
